Acrylamide compounds as histamine h3 receptor ligands

The present invention relates to novel acrylamide compounds of formula (I), and their pharmaceutically acceptable salts and process of their preparation. The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H3 receptors, including cognitive deficits...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NIROGI RAMAKRISHNA, SHINDE ANIL KARBHARI, DWARAMPUDI ADI REDDY, JASTI VENKATESWARLU
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator NIROGI RAMAKRISHNA
SHINDE ANIL KARBHARI
DWARAMPUDI ADI REDDY
JASTI VENKATESWARLU
description The present invention relates to novel acrylamide compounds of formula (I), and their pharmaceutically acceptable salts and process of their preparation. The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H3 receptors, including cognitive deficits in schizophrenia, narcolepsy, obesity, attention deficit hyperactivity disorder, pain and/or alzheimer's disease.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ703323A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ703323A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ703323A3</originalsourceid><addsrcrecordid>eNrjZDB1TC6qzEnMzUxJVUjOzy3IL81LKVZILFbIyCwuAQrnpSpkGCsUpSanFpTkFynkZKYnAhXwMLCmJeYUp_JCaW4GOTfXEGcP3dSC_PjU4oLE5NS81JJ4vyhzA2NjI2NHY4IKAGkzLBI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Acrylamide compounds as histamine h3 receptor ligands</title><source>esp@cenet</source><creator>NIROGI RAMAKRISHNA ; SHINDE ANIL KARBHARI ; DWARAMPUDI ADI REDDY ; JASTI VENKATESWARLU</creator><creatorcontrib>NIROGI RAMAKRISHNA ; SHINDE ANIL KARBHARI ; DWARAMPUDI ADI REDDY ; JASTI VENKATESWARLU</creatorcontrib><description>The present invention relates to novel acrylamide compounds of formula (I), and their pharmaceutically acceptable salts and process of their preparation. The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H3 receptors, including cognitive deficits in schizophrenia, narcolepsy, obesity, attention deficit hyperactivity disorder, pain and/or alzheimer's disease.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160331&amp;DB=EPODOC&amp;CC=NZ&amp;NR=703323A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160331&amp;DB=EPODOC&amp;CC=NZ&amp;NR=703323A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NIROGI RAMAKRISHNA</creatorcontrib><creatorcontrib>SHINDE ANIL KARBHARI</creatorcontrib><creatorcontrib>DWARAMPUDI ADI REDDY</creatorcontrib><creatorcontrib>JASTI VENKATESWARLU</creatorcontrib><title>Acrylamide compounds as histamine h3 receptor ligands</title><description>The present invention relates to novel acrylamide compounds of formula (I), and their pharmaceutically acceptable salts and process of their preparation. The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H3 receptors, including cognitive deficits in schizophrenia, narcolepsy, obesity, attention deficit hyperactivity disorder, pain and/or alzheimer's disease.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDB1TC6qzEnMzUxJVUjOzy3IL81LKVZILFbIyCwuAQrnpSpkGCsUpSanFpTkFynkZKYnAhXwMLCmJeYUp_JCaW4GOTfXEGcP3dSC_PjU4oLE5NS81JJ4vyhzA2NjI2NHY4IKAGkzLBI</recordid><startdate>20160331</startdate><enddate>20160331</enddate><creator>NIROGI RAMAKRISHNA</creator><creator>SHINDE ANIL KARBHARI</creator><creator>DWARAMPUDI ADI REDDY</creator><creator>JASTI VENKATESWARLU</creator><scope>EVB</scope></search><sort><creationdate>20160331</creationdate><title>Acrylamide compounds as histamine h3 receptor ligands</title><author>NIROGI RAMAKRISHNA ; SHINDE ANIL KARBHARI ; DWARAMPUDI ADI REDDY ; JASTI VENKATESWARLU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ703323A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NIROGI RAMAKRISHNA</creatorcontrib><creatorcontrib>SHINDE ANIL KARBHARI</creatorcontrib><creatorcontrib>DWARAMPUDI ADI REDDY</creatorcontrib><creatorcontrib>JASTI VENKATESWARLU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NIROGI RAMAKRISHNA</au><au>SHINDE ANIL KARBHARI</au><au>DWARAMPUDI ADI REDDY</au><au>JASTI VENKATESWARLU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Acrylamide compounds as histamine h3 receptor ligands</title><date>2016-03-31</date><risdate>2016</risdate><abstract>The present invention relates to novel acrylamide compounds of formula (I), and their pharmaceutically acceptable salts and process of their preparation. The compounds of formula (I) are useful in the treatment of various disorders that related to Histamine H3 receptors, including cognitive deficits in schizophrenia, narcolepsy, obesity, attention deficit hyperactivity disorder, pain and/or alzheimer's disease.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_NZ703323A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Acrylamide compounds as histamine h3 receptor ligands
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T07%3A03%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NIROGI%20RAMAKRISHNA&rft.date=2016-03-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ703323A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true